Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 17, 2022 - Issue
Submit an article Journal homepage
289
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Comparing Clinical Outcomes of Tiotropium/Olodaterol, Umeclidinium/Vilanterol, and Indacaterol/Glycopyrronium Fixed-Dose Combination Therapy in Patients with Chronic Obstructive Pulmonary Disease in Taiwan: A Multicenter Cohort Study

Meng-Jer Hsieh1 Department of Pulmonary and Critical Care Medicine, Linkou Chang Gung Memorial Hospital, Chang Gung Medical Foundation and Department of Respiratory Therapy, College of Medicine, Chang Gung University, Taoyuan, TaiwanORCID Iconhttps://orcid.org/0000-0002-2077-0470View further author information
ORCID Icon,
Ning-Hung Chen2 Department of Pulmonary and Critical Care Medicine, Linkou Chang Gung Memorial Hospital and School of Traditional Chinese Medicine, Chang Gung University, Taoyuan, TaiwanView further author information
,
Shih-Lung Cheng3 Department of Internal Medicine, Far Eastern Memorial Hospital, Taipei, Taiwan;4 Department of Chemical Engineering and Materials Science, Yuan Ze University, Zhongli, Taoyuan, TaiwanView further author information
,
Chi-Wei Tao5 Department of Internal Medicine, Cheng-Hsin General Hospital, Taipei, TaiwanView further author information
,
Yu-Feng Wei6 School of Medicine for International Students, College of Medicine, I-Shou University, Kaohsiung, Taiwan;7 Department of Internal Medicine, E-Da Cancer Hospital, Kaohsiung, TaiwanORCID Iconhttps://orcid.org/0000-0002-6380-3527View further author information
ORCID Icon,
Yao-Kuang Wu8 Division of Pulmonary Medicine, Department of Internal Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, TaiwanORCID Iconhttps://orcid.org/0000-0001-7898-6963View further author information
ORCID Icon,
Ming-Cheng Chan9 Division of Critical Care and Respiratory Therapy, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan;10 National Chung Hsing University, Taichung, TaiwanView further author information
,
Shih-Feng Liu11 Department of Respiratory Therapy, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan;12 Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan;13 College of Medicine, Chang Gung University, Taoyuan, TaiwanORCID Iconhttps://orcid.org/0000-0003-1394-5401View further author information
ORCID Icon,
Wu-Huei Hsu14 Critical Medical Center, China Medical University Hospital, Taichung, TaiwanView further author information
,
Tsung-Ming Yang15 Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chiayi Chang Gung Memorial Hospital, Chiayi, TaiwanView further author information
,
Ming-Shian Lin16 Division of Pulmonary Medicine, Department of Internal Medicine, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi, Taiwan;17 Department of Respiratory Care, Chang Gung University of Science and Technology, Chiayi, TaiwanView further author information
,
Ching-Lung Liu18 Division of Chest Medicine, Department of Internal Medicine, MacKay Memorial Hospital, Taipei, TaiwanView further author information
,
Ping-Hung Kuo19 Department of Internal Medicine, National Taiwan University Hospital, Taipei, TaiwanORCID Iconhttps://orcid.org/0000-0003-3756-3395View further author information
ORCID Icon &
Ying-Huang Tsai1 Department of Pulmonary and Critical Care Medicine, Linkou Chang Gung Memorial Hospital, Chang Gung Medical Foundation and Department of Respiratory Therapy, College of Medicine, Chang Gung University, Taoyuan, Taiwan;20 Department of Pulmonary and Critical Care Medicine, Xiamen Chang Gung Hospital, Xiamen, 361028, People’s Republic of ChinaCorrespondence[email protected]
View further author information
 show all
Pages 967-976 | Published online: 27 Apr 2022

References

  • Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease—2020 report. Available from: https://goldcopd.org/wp-content/uploads/2019/11/GOLD-2020-REPORT-ver1.0wms.pdf. Accessed April 1, 2022.
  • World Health Organization. The top 10 causes of death. WHO. Available from: http://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death; 2020. Accessed 23 November, 2020.
  • Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2163–2196.
  • Ministry of Health and Welfare, Taiwan. Taiwan’s Leading Causes of Death in 2016. Ministry of Health and Welfare; 2017. Available from: https://www.mohw.gov.tw/cp-3425-33347-2.html. Accessed November 23, 2018.
  • Cheng SL, Chan MC, Wang CC, et al. COPD in Taiwan: a National Epidemiology Survey. Int J Chron Obstruct Pulmon Dis. 2015;10:2459–2467.
  • Wedzicha JA, Seemungal TA. COPD exacerbations: defining their cause and prevention. Lancet. 2007;370(9589):786–796.
  • Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128–1138.
  • Ho TW, Tsai YJ, Ruan SY, Huang CT, Lai F, Yu CJ. In-hospital and one-year mortality and their predictors in patients hospitalized for first-ever chronic obstructive pulmonary disease exacerbations: a nationwide population-based study. PLoS One. 2014;9(12):e114866.
  • Mammen MJ, Pai V, Aaron SD, Nici L, Alhazzani W, Alexander PE. Dual LABA/LAMA Therapy versus LABA or LAMA Monotherapy for Chronic Obstructive Pulmonary Disease. A Systematic Review and Meta-analysis in Support of the American Thoracic Society Clinical Practice Guideline. Ann Am Thorac Soc. 2020;17(9):1133–1143.
  • Rogliani P, Matera MG, Ritondo BL, et al. Efficacy and cardiovascular safety profile of dual bronchodilation therapy in chronic obstructive pulmonary disease: a bidimensional comparative analysis across fixed-dose combinations. Pulm Pharmacol Ther. 2019;59:101841.
  • Lee HW, Park J, Jang EJ, Lee CH. Comparisons of exacerbations and mortality among LAMA/LABA combinations in stable chronic obstructive pulmonary disease: systematic review and Bayesian network meta-analysis. Respir Res. 2020;21(1):310.
  • Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648–654.
  • Kon SS, Canavan JL, Jones SE, et al. Minimum clinically important difference for the COPD Assessment Test: a prospective analysis. Lancet Respir Med. 2014;2(3):195–203.
  • Cazzola M, Hanania NA, MacNee W, Rüdell K, Hackford C, Tamimi N. A review of the most common patient-reported outcomes in COPD–revisiting current knowledge and estimating future challenges. Int J Chron Obstruct Pulmon Dis. 2015;10:725–738.
  • Calverley PMA, Anzueto AR, Carter K, et al. Tiotropium and olodaterol in the prevention of chronic obstructive pulmonary disease exacerbations (DYNAGITO): a double-blind, randomised, parallel-group, active-controlled trial. Lancet Respir Med. 2018;6(5):337–344.
  • Ichinose M, Nishimura M, Akimoto M, et al. Tiotropium/olodaterol versus tiotropium in Japanese patients with COPD: results from the DYNAGITO study. Int J Chron Obstruct Pulmon Dis. 2018;13:2147–2156.
  • Feldman GJ, Sousa AR, Lipson DA, et al. Comparative Efficacy of Once-Daily Umeclidinium/Vilanterol and Tiotropium/Olodaterol Therapy in Symptomatic Chronic Obstructive Pulmonary Disease: a Randomized Study. Adv Ther. 2017;34(11):2518–2533.
  • Buhl R, Maltais F, Abrahams R, et al. Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2-4). Eur Respir J. 2015;45(4):969–979.
  • Singh D, Ferguson GT, Bolitschek J, et al. Tiotropium + olodaterol shows clinically meaningful improvements in quality of life. Respir Med. 2015;109(10):1312–1319.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.